Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02712398 · ClinicalTrials.gov registry record · NA
A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair
A NA study, sponsored by C. R. Bard.
- Completed
- Registry status
- NA
- Development phase
- 120
- Enrollment target
NCT02712398 is a NA study that has completed, run by C. R. Bard. The registered enrollment target is 120 participants.
The verdict
NCT02712398, a NA study, has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
Study Summary
The objective of this study is to collect additional data on safety, performance and effectiveness of Phasix™ ST in subjects receiving laparoscopic ventral or incisional hernia repair at high risk for surgical site occurrence (SSO).
Interventions
- DEVICE Phasix™ ST
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02712398
The ClinicalTrials.gov registry entry for NCT02712398 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 75 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Phasix™ ST is the first listed.
NCT02712398 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02712398 about?
NCT02712398 is a clinical study titled "A Prospective Trial of a Bio-absorbable Mesh in Challenging Laparoscopic Ventral or Incisional Hernia Repair". The objective of this study is to collect additional data on safety, performance and effectiveness of Phasix™ ST in subjects receiving laparoscopic ventral or incisional hernia repair at high risk for surgical site occurrence (SSO).
What is the current status of trial NCT02712398?
This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2016-04. Estimated completion is 2019-11-15.
What interventions are being tested in trial NCT02712398?
The interventions under investigation include: Phasix™ ST (DEVICE).
Who is sponsoring clinical trial NCT02712398?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.